TalkMed Group Past Earnings Performance
Past criteria checks 4/6
TalkMed Group's earnings have been declining at an average annual rate of -0.7%, while the Healthcare industry saw earnings growing at 15.1% annually. Revenues have been growing at an average rate of 3.4% per year. TalkMed Group's return on equity is 34.9%, and it has net margins of 38.4%.
Key information
-0.7%
Earnings growth rate
-0.9%
EPS growth rate
| Healthcare Industry Growth | 9.7% |
| Revenue growth rate | 3.4% |
| Return on equity | 34.9% |
| Net Margin | 38.4% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How TalkMed Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 84 | 32 | 1 | 0 |
| 30 Sep 23 | 83 | 32 | 1 | 0 |
| 30 Jun 23 | 82 | 33 | 1 | 0 |
| 31 Mar 23 | 79 | 32 | 1 | 0 |
| 31 Dec 22 | 77 | 31 | 1 | 0 |
| 30 Sep 22 | 70 | 28 | 1 | 0 |
| 30 Jun 22 | 64 | 26 | 1 | 0 |
| 31 Mar 22 | 63 | 26 | 1 | 0 |
| 31 Dec 21 | 61 | 25 | 1 | 0 |
| 30 Sep 21 | 62 | 25 | 1 | 0 |
| 30 Jun 21 | 60 | 23 | 1 | 0 |
| 31 Mar 21 | 61 | 23 | 1 | 0 |
| 31 Dec 20 | 62 | 23 | 2 | 0 |
| 30 Sep 20 | 67 | 27 | 2 | 0 |
| 30 Jun 20 | 71 | 31 | 2 | 0 |
| 31 Mar 20 | 74 | 34 | 1 | 0 |
| 31 Dec 19 | 76 | 36 | 0 | 0 |
| 30 Sep 19 | 73 | 34 | 1 | 0 |
| 30 Jun 19 | 71 | 33 | 1 | 0 |
| 31 Mar 19 | 66 | 31 | 2 | 0 |
| 31 Dec 18 | 61 | 29 | 2 | 0 |
| 30 Sep 18 | 58 | 28 | 3 | 0 |
| 30 Jun 18 | 55 | 27 | 2 | 0 |
| 31 Mar 18 | 57 | 29 | 2 | 0 |
| 31 Dec 17 | 61 | 32 | 2 | 0 |
| 30 Sep 17 | 65 | 34 | 2 | 0 |
| 30 Jun 17 | 68 | 35 | 2 | 0 |
| 31 Mar 17 | 69 | 37 | 2 | 0 |
| 31 Dec 16 | 69 | 37 | 2 | 0 |
| 30 Sep 16 | 68 | 37 | 1 | 0 |
| 30 Jun 16 | 67 | 36 | 1 | 0 |
| 31 Mar 16 | 66 | 36 | 1 | 0 |
| 31 Dec 15 | 66 | 37 | 1 | 0 |
| 30 Sep 15 | 65 | 38 | 1 | 0 |
| 30 Jun 15 | 65 | 40 | 1 | 0 |
| 31 Mar 15 | 65 | 40 | 1 | 0 |
| 31 Dec 14 | 63 | 39 | 1 | 0 |
| 30 Sep 14 | 61 | 32 | 1 | 0 |
| 30 Jun 14 | 59 | 31 | 1 | 0 |
| 31 Mar 14 | 58 | 30 | 0 | 0 |
| 31 Dec 13 | 56 | 28 | 0 | 0 |
| 30 Sep 13 | 55 | 32 | 0 | 0 |
| 30 Jun 13 | 54 | 32 | 0 | 0 |
Quality Earnings: 5G3 has high quality earnings.
Growing Profit Margin: 5G3's current net profit margins (38.4%) are lower than last year (39.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 5G3's earnings have declined by 0.7% per year over the past 5 years.
Accelerating Growth: 5G3's earnings growth over the past year (5.3%) exceeds its 5-year average (-0.7% per year).
Earnings vs Industry: 5G3 earnings growth over the past year (5.3%) exceeded the Healthcare industry -2%.
Return on Equity
High ROE: 5G3's Return on Equity (34.9%) is considered high.